J&J News - Facebook
J&J News. 55,361 likes · 9,875 talking about this. J&J News brings you all the facts.
Johnson & Johnson (JNJ) Latest Stock News & Headlines
Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions.
J&J plans to split into two companies, separating consumer …
Nov 12, 2021 · Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded...
J&J beats Wall St estimates on strong drug sales ahead of Stelara ...
July 17 (Reuters) - Johnson & Johnson (JNJ.N) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and...
Latest news - Johnson & Johnson
Sep 10, 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Exclusive: J&J near disclosing support for talc settlement, sources …
NEW YORK, Aug 14 (Reuters) - Johnson & Johnson (JNJ.N) is preparing to unveil widespread support in coming days for a $6.48 billion offer to settle tens of thousands of legal actions alleging its...
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Innovative Medicine. Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Additional data show a booster increases protection. 94 percent protection in the U.S. with booster given at two months.
With J&J pushing a 3rd talc bankruptcy, court affirms earlier loss
NEW YORK, July 26 (Reuters) - A U.S. appeals court has affirmed a decision that ended J&J's second attempt to resolve tens of thousands of cancer lawsuits through a shell company's...
J&J’s strong quarter was amplified by new details around its
Jul 20, 2023 · Johnson & Johnson (JNJ) reported strong second - quarter profit and revenue before the opening bell Thursday, with better-than-expected results both domestically and internationally, as well as...
Positive New Data for Johnson & Johnson Single-Shot COVID-19 …
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 …